These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Pressor response after intravenous labetalol. Crofton M; Gabriel R Br Med J; 1977 Sep; 2(6089):737. PubMed ID: 912276 [No Abstract] [Full Text] [Related]
45. [Studies on the pathogenesis of hydralazine-induced lupus erythematosus-like syndrome (author's transl)]. Yamauchi Y Ryumachi; 1979 Apr; 19(2):88-104. PubMed ID: 312536 [No Abstract] [Full Text] [Related]
46. [Clinical significance of antinuclear antibodies in systemic lupus erythematosus]. Stefanović Z; Mijailović B Vojnosanit Pregl; 1986; 43(1):16-21. PubMed ID: 3515753 [No Abstract] [Full Text] [Related]
57. Side effects of labetalol in newborn infants. Woods DL; Malan AF Br J Obstet Gynaecol; 1983 Sep; 90(9):876. PubMed ID: 6615747 [No Abstract] [Full Text] [Related]
58. [D-penicillamine induced lupus during the treatment of rheumatoid arthritis. Report of 2 cases and systematic immunologic study during the treatment]. Crouzet J; Camus JP; Leca AP; Guillien P; Lièvre JA Ann Med Interne (Paris); 1974 Jan; 125(1):71-9. PubMed ID: 4136184 [No Abstract] [Full Text] [Related]
59. Scalp tingling in patients on labetalol. Hua AS; Thomas GW; Kincaid-Smith P Lancet; 1977 Aug; 2(8032):295. PubMed ID: 69898 [No Abstract] [Full Text] [Related]